Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03253705 · ClinicalTrials.gov registry record
Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research
A clinical trial of Healthy Volunteers and Endothelial Dysfunction, sponsored by National Institutes of Health Clinical Center (CC).
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03253705: Recruiting study of Healthy Volunteers and Endothelial Dysfunction, sponsored by National Institutes of Health Clinical Center (CC).
NCT03253705 is a study of Healthy Volunteers and Endothelial Dysfunction that is actively recruiting participants, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 1,000 participants, above the 478-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (109% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03253705, a study of Healthy Volunteers and Endothelial Dysfunction, is actively recruiting participants, sponsored by National Institutes of Health Clinical Center (CC).
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: This study is designed to provide samples to help us study the genes your blood cells are making as well as the proteins, sugars, fats, vitamins and other metabolites found in your blood or urine. Blood samples may also be collected to make special cells. These are called induced pluripotent stem cells or iPSCs. Pluripotent stem cells are cells that can be converted into any type of cell. Researchers want to study in the lab iPSCs that are derived from blood samples. Objective: To collect samples to help study genes, proteins, sugars, fats, vitamins, and other metabolites found in blood or urine. Eligibility: Healthy volunteers and patients ages 18 and older Design: First-time research study participants at NIH will have an initial visit for this study that should last no more than 1 hour. All other visits should last 20 30 minutes. Participants will undergo a limited history and physical exam. Participants may have routine blood and urine tests. If participants are giving a blood sample, they must have a hemoglobin level checked in the past 12 months to make sure it is safe for them to give a blood sample for research. Participants may have a venous blood collection. They may do this at several visits. They will lie on a recliner or couch or sit in a chair. A needle will be placed into a vein in the hand or arm, using sterile techniques. Blood will be withdrawn into multiple syringes or tubes. Participants may be asked to provide urine in an appropriate container...
Primary Outcome
Development of new assays
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-09-14 |
| Est. Completion | 2027-08-01 |
What NCT03253705 shows while recruiting
NCT03253705 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 478-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (109% higher).
The record links to 3 conditions, with Healthy Volunteers appearing as the primary indexed condition, and to 0 interventions.
NCT03253705 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03253705 about?
NCT03253705 is a clinical study titled "Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research". Background: This study is designed to provide samples to help us study the genes your blood cells are making as well as the proteins, sugars, fats, vitamins and other metabolites found in your blood or urine. Blood samples may also be collected to make special cells. These are called induced plurip...
What is the current status of trial NCT03253705?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2017-09-14. Estimated completion is 2027-08-01.
What conditions does trial NCT03253705 study?
This clinical trial studies the following conditions: Healthy Volunteers, Endothelial Dysfunction, Inflammation in Cardiopulmonary and Vascular Disease States.
Who is sponsoring clinical trial NCT03253705?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03253705 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03253705's enrollment target sits among peer trials
1,000 14th of 283 higher than 265 of 283 other Healthy Volunteers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adaptive Optics Retinal Imaging
RECRUITING
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
RECRUITING · Phase 1
-
Acute Effects of High-intensity Interval Training With Mindfulness-based Recovery on Executive Function in Children
RECRUITING · NA
-
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
RECRUITING · Phase 1
-
Children s Growth and Behavior Study
RECRUITING
-
New Heart Imaging Techniques to Evaluate Possible Heart Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI